Methandriol
Methandriol
Methandriol (pronunciation: meh-than-dree-ol) is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of dihydrotestosterone (DHT) that is marketed in Australia and Europe. It is a controlled substance in many countries due to its potential for misuse in sports.
Etymology
The term "Methandriol" is derived from the chemical structure of the compound, which includes a methylene group (meth-) and a hydroxyl group (-ol). The "andriol" part of the name is a common suffix used in the naming of androgenic steroids.
Usage
Methandriol is used in the treatment of hypogonadism, delayed puberty, and certain types of breast cancer. It is also used illicitly for physique- or performance-enhancing purposes by competitive athletes, bodybuilders, and powerlifters.
Side Effects
Like other anabolic steroids, methandriol has potential side effects, including hepatotoxicity, cardiovascular disease risks, and endocrine system disruption. It can also cause androgenic side effects like acne, hair loss, and increased aggression.
Related Terms
- Anabolic steroid
- Androgen
- Hypogonadism
- Delayed puberty
- Breast cancer
- Hepatotoxicity
- Cardiovascular disease
- Endocrine system
External links
- Medical encyclopedia article on Methandriol
- Wikipedia's article - Methandriol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski